Los Angeles Capital Management LLC Pulmonx Corp Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022
SELL
$29.72 - $45.1 $542,657 - $823,480
-18,259 Closed
0 $0
Q3 2021

Nov 08, 2021
SELL
$35.98 - $44.48 $59,007 - $72,947
-1,640 Reduced 8.24%
18,259 $657,000
Q2 2021

Aug 05, 2021
SELL
$37.61 - $48.0 $47,388 - $60,480
-1,260 Reduced 5.95%
19,899 $878,000
Q1 2021

May 05, 2021
BUY
$44.0 - $67.54 $930,996 - $1.43 Million
21,159 New
21,159 $967,000

Others Institutions Holding LUNG

# of Institutions
125
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $252M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email